167 related articles for article (PubMed ID: 22471181)
1. A coverage evaluation survey of JE vaccination in two districts of Karnataka.
Kumar KR; Basha R; Harish BR; Sanjay TV; Vinay M; Prabhu S; Babu R
J Commun Dis; 2010 Sep; 42(3):179-84. PubMed ID: 22471181
[TBL] [Abstract][Full Text] [Related]
2. Coverage & missed opportunity for Japanese encephalitis vaccine, Gorakhpur division, Uttar Pradesh, India, 2015: Implications for Japanese encephalitis control.
Murhekar MV; Oak C; Ranjan P; Kanagasabai K; Shinde S; Pandey AK; Mittal M; Gore M; Mehendale SM
Indian J Med Res; 2017 Jan; 145(1):63-69. PubMed ID: 28574016
[TBL] [Abstract][Full Text] [Related]
3. Adverse events following immunisation with SA 14-14-2 Japanese encephalitis vaccine in children of Kolar in Karnataka.
Ranganath BG; Hiremath SG
J Indian Med Assoc; 2012 Jan; 110(1):10-2. PubMed ID: 23029822
[TBL] [Abstract][Full Text] [Related]
4. An economic evaluation of the use of Japanese encephalitis vaccine in the expanded program of immunization of Guizhou province, China.
Yin Z; Beeler Asay GR; Zhang L; Li Y; Zuo S; Hutin YJ; Ning G; Sandhu HS; Cairns L; Luo H;
Vaccine; 2012 Aug; 30(37):5569-77. PubMed ID: 22698453
[TBL] [Abstract][Full Text] [Related]
5. Updated estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal.
Upreti SR; Lindsey NP; Bohara R; Choudhary GR; Shakya S; Gautam M; Giri JN; Fischer M; Hills SL
PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005866. PubMed ID: 28934197
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of Japanese encephalitis (JE) immunization in Bali, Indonesia.
Liu W; Clemens JD; Kari K; Xu ZY
Vaccine; 2008 Aug; 26(35):4456-60. PubMed ID: 18602436
[TBL] [Abstract][Full Text] [Related]
7. A model immunization programme to control Japanese encephalitis in Viet Nam.
Yen NT; Liu W; Hanh HD; Chang NY; Duong TN; Gibbons RV; Marks F; Thu NA; Hong NM; Park JK; Tuan PA; Nisalak A; Clemens JD; Xu ZY
J Health Popul Nutr; 2015 Mar; 33(1):207-13. PubMed ID: 25995736
[TBL] [Abstract][Full Text] [Related]
8. Primary immunization of infants and toddlers in Thailand with Japanese encephalitis chimeric virus vaccine in comparison with SA14-14-2: a randomized study of immunogenicity and safety.
Feroldi E; Pancharoen C; Kosalaraksa P; Chokephaibulkit K; Boaz M; Meric C; Hutagalung Y; Bouckenooghe A
Pediatr Infect Dis J; 2014 Jun; 33(6):643-9. PubMed ID: 24717964
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of Japanese encephalitis in South Korea, 2007-2010.
Lee DW; Choe YJ; Kim JH; Song KM; Cho H; Bae GR; Lee JK
Int J Infect Dis; 2012 Jun; 16(6):e448-52. PubMed ID: 22497964
[TBL] [Abstract][Full Text] [Related]
10. Reduction patterns of Japanese encephalitis incidence following vaccine introduction into long-term expanded program on immunization in Yunnan Province, China.
Hu XT; Li QF; Ma C; Zhao ZX; He LF; Tang TT; Yu W; Owiti P
Infect Dis Poverty; 2019 Dec; 8(1):102. PubMed ID: 31818328
[TBL] [Abstract][Full Text] [Related]
11. Japanese encephalitis vaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy.
Puthanakit T; Aurpibul L; Yoksan S; Sirisanthana T; Sirisanthana V
Vaccine; 2007 Nov; 25(49):8257-61. PubMed ID: 17964009
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of a single dose of Japanese encephalitis vaccine among adults, Assam, India, 2012-2018.
Khan SA; Choudhury P; Kakati S; Doley R; Barman MP; Murhekar MV; Kaur H
Vaccine; 2021 Aug; 39(35):4973-4978. PubMed ID: 34325931
[TBL] [Abstract][Full Text] [Related]
13. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
Zhou B; Jia L; Xu X
Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
[TBL] [Abstract][Full Text] [Related]
14. Impact of SA 14-14-2 vaccination on the occurrence of Japanese encephalitis in India.
Muniaraj M; Rajamannar V
Hum Vaccin Immunother; 2019; 15(4):834-840. PubMed ID: 30681400
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of Japanese encephalitis SA 14-14-2 live attenuated vaccine among Indian children: Retrospective 1:4 matched case-control study.
Tandale BV; Khan SA; Kushwaha KP; Rahman H; Gore MM;
J Infect Public Health; 2018; 11(5):713-719. PubMed ID: 29703709
[TBL] [Abstract][Full Text] [Related]
16. Immunization against Japanese encephalitis in China: a policy analysis.
Liu W; Clemens JD; Yang JY; Xu ZY
Vaccine; 2006 Jun; 24(24):5178-82. PubMed ID: 16697091
[TBL] [Abstract][Full Text] [Related]
17. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
[TBL] [Abstract][Full Text] [Related]
18. Cost benefit analysis of Japanese encephalitis vaccination program in Thailand.
Siraprapasiri T; Sawaddiwudhipong W; Rojanasuphot S
Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):143-8. PubMed ID: 9322297
[TBL] [Abstract][Full Text] [Related]
19. High vaccination coverage, inadequate knowledge and high vector density: Findings from a community-based cross-sectional study on Japanese Encephalitis in Yangon, Myanmar.
Kyaw PP; Shewade HD; Kyaw NTT; Hnin Phyo K; Lin HH; Kyaw AMM; Mya MM; Thaung S; Maung Maung YN
F1000Res; 2020; 9():6. PubMed ID: 33014343
[No Abstract] [Full Text] [Related]
20. High vaccination coverage and inadequate knowledge: Findings from a community-based cross-sectional study on Japanese Encephalitis in Yangon, Myanmar.
Kyaw PP; Shewade HD; Kyaw NTT; Hnin Phyo K; Lin HH; Kyaw AMM; Mya MM; Thaung S; Maung Maung YN
F1000Res; 2020; 9():6. PubMed ID: 33014342
[No Abstract] [Full Text] [Related]
[Next] [New Search]
